chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine was received on 01/23/2021 at ~4:00 PM. My wife was notified that she was exposed while administering vaccines at a site on the same day. On the afternoon of the 26th I began to feel a sore throat, headache and low grade fever. By the 27th. I continued with intermittent headaches, sore throat and fevers of between 99.8 and 101. On 01/28/2021 I was tested for Covid and it came back negative. I continued with the same symptoms and on 02/02/2021 I was retested and the results again came back negative. My symptoms have not deminished and today 02/05/2021 I had a virtual meeting with my primary PA. She has prescribed Zythromax and asked me to follow up with her in a few days.
Note: The pt was lying on her back, shaking, and biting her tongue. She was rolled to her side. The APRN on site came to evaluate the patient. APRN, came up to examine pt.  Ativan orders and administered seizure activity occurred at  10:45.  Ativan was administered at 11:05.  Pt opened their eyes and became conscious at 11:20.
PT RECEIVED THE IM SHOT AND IMMEDIATELY SLUMPED AND WAS CLAMMY. EYES ROLLED BACK SOME WHAT AND HE WENT LIMP. PT JERKED A COUPLE OF TIMES. WITH IN 20 SECONDS HE WAS RESPONDING TO HIS GRANDPA. HE CAME TO AND SIPPED ON SPRITE AND WITH IN 5 MINUTES SAID HE WAS OK. HE STAYED FOR 20 MINUTES AND LEFT AS THE PARAMEDICS ARRIVED. THE PARAMEDIC AGREED THAT THE PATIENT WAS OK. PT HAD TALKED A LOT ABOUT HOW DISCOMFORTED HE HAD BEEN WHEN HE GOT THE TDAP SHOT AT HIS DAD'S WORK LAST WEEK.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 3:25 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 3:25 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 26.25.  No concomitant medications were reported.  Batch number 044B21A administered on 15-Apr-2021 had  temperature 34 at 09:00 AM. This vial was moved to fridge on 06-Apr-2021 and beyond use date for the vial was reported as 09-May-2021. Product moved to clinic on 15-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported
Developed acute inspiratory wheeze approximately 6 hours after the vaccination was received. Wheeze persisted for 30 hours
Immunized and approx 24 hours post immunization Pt started getting "bumps" all over upper body. head, chest, back, arms, neck. Complaint of itching. Pt seen by provider on the 20th, and received Benadryl. The "bumps" are currently resolving.
Dizziness & clammy. No LOC; AOx4; dizziness resolved, skin warm & dry after 15 min (BP 131/67; HR 80; RR 15). Pt stable & released from vaccination site
Patient stated he felt as if he was going to faint and that this feeling happens often when he receives shots or sees needles. EMS was called and EMS took vitals. BP: 113/62. HR: 60. Patient stated he felt better after several minutes and EMS sent patient home.
Patient received 2nd dose on 2/2 at 0733.  Patient missed worked on 2/3/21 due to "effects from COVID vaccine".  Patient was unable to go to work due to disorientation, confusion, headache, and chills.  The patient's employee health department advised the patient's family to send patient to be seen by ED.  Per ED note patient had complaint of intermittent confusion and disorientation, and fever.  Symptoms started after he received his second Covid vaccine.  Patient was alert and oriented when seen by ED physician.  Patient described symptoms as coming and going,  have been worse when he first wakes up.  Patient has a past history of seizures and TIA.  Provider admitted to make sure he was not having further seizures or TIA.  Patient was observed and discharged on feb 5.  Per discharging provider the patient had some mild low-grade fever with negative cultures.  Provider unsure if fever due to vaccine or mild case of bronchitis-patient discharged on a Zithromax pack.
Flu-like symptoms; Low grade fever; This is a spontaneous report from a contactable consumer. A non-pregnant 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration, in Mar2021 (at the age of 62 years), as dose number unknown, single, for COVID-19 immunization. The patient's medical history included COVID-19 (prior to vaccination). The patient's concomitant medications were not reported. In Mar2021, the patient experienced flu-like symptoms and low grade fever. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot or batch number cannot be obtained. No further information is expected.
Breakthrough COVID-19 Case: I started with symptoms in the evening of May 1st that were almost cold like symptoms. By Monday morning, May 2nd, I did have fever and chills, coughing, fatigue, sore throat. I took the antigen test, and it came out positive. I made an appointment to have a PCR test that afternoon. I continued to have increased symptoms, more coughing congestion. I got the PCR test back the next day and it was positive. I called the doctor and they sent me to Urgent Care where they gave me a Z Pack and Benzonatate 200mg. I just been doing that ever since. I feel a little better today...day 8, I guess. I'm starting to cough less and still have congestion. No more fever or anything like that though.
Aches and pain, fatigue, tiredness, swollen armpit lymph node, headache
Burning/stinging upon injection. Instant arm pain. Tingling/ Pins and needles sensation in both feet upon standing. About 2 minutes later - burning sensation in ears which subsided within a minutes. 7 minutes after shot - Rapid heartbeat and brief shortness of breath  which subsided after a couple minutes. 45 minutes after shot - more shortness of breath and dizziness which subsided after a few minutes. "Brain fog" for the remainder of the day. Arm pain and occasional shortness of breath during the following 5 days.
Increasing arm pain next two days, the pain remains the same after 11 days. It feels like the bicep muscle locks up, severe stabbing pain when lifting, raising or contracting the muscle. Extremely painful from the shoulder joint and down near the elbow. Expect some pain after but not this long or severe.
Moderate pain in injection site for first two days (02/02/2021, 02/03/2021). Nausea, lower back pain, knee pain, sore throat, low-grade fever (~99°F) and persistent headache, and took Theraflu nighttime before bed on day two (02/03/2021). Temperature of 99.7°F throughout day three (02/04/2021); also, lower back pain, knee pain, sore throat with swollen lymph nodes and tonsils with white spots (did at-home test for strep-A, got a negative result), and persistent headache?this night I also took Theraflu nighttime. Day 4 (02/05/2021), I woke up around 7AM  with severe nausea and went back to sleep after having ginger ale; throughout the early afternoon I had mild lower back and knee pain, same throat and tonsil situation, mild headache, and diarrhea. I ended up drinking a lot of water and had a glass of emergen-c as well as taking two pepto bismol tablets. Less than an hour later, I threw up everything I?d consumed throughout the day (water, hot tea, and emergen-c, no food due to nausea). Tried eating plain white rice and drinking  beer that evening but I couldn?t keep it down. Day 5 (today, 02/06/2022), I woke up with only lower back pain, same tonsil/throat situation, headache, and a slightly higher fever- 100.2°F. So far no nausea.
Patient received two MENACTRA vaccines. #1 on 11-5-07 and #2 on 7-17-08
Client reported itchiness and redness in face during monitoring period post-vaccination. IV Benadryl was given and symptom resolved. Client was transported to ER for further evaluation.
Chills & Fever started around 4:00am 5/5/21, some body aches- nothing major. Body aches went away around 6:30am. Took advil around 5:30 AM, fever was around 100.4 around then, dropped down back to 98 degrees 2 hours later. Took a nap a few hours later around 1pm after eating, fever spiked again to 101.7, took some Tylenol, fever did not reduce. Took another nap, woke up around 4:45 pm fever was at 102.7. Took Tylenol again around 5:30pm- fever went down around anywhere from 11:00pm-2:00am. 5/7/21- took temp was normal 96.6 degrees, went to work. Drinking lots of water, feeling extremely dizzy and chills still- minor chills, but temperature is reading around 98 degrees (electronic reading)
Patient received the Jansen covid-19 vaccine today.   he was fine when he received the vaccine but when he was sitting in the chair in the pharmacy lobby he fainted.   I saw him fall out of chair and immediately ran out the door to assist him.  He fell out of chair face down on the floor.  When I reached him I rolled him over and spoke to him and he responded to me.  I had him remain on the floor for several minutes before I had him sit in the chair.  He bit his lip and there was a spot of blood and he hit his forehead on the floor.   We called emergency number and emergency medical team arrived shortly and took his vital signs and they were normal.   He was a little clammy and sweating a little.   I gave him a bottle of cold water to drink while he was sitting.   The emergency team checked him out and they ask him if he wanted to go to hospital and he declined going.   The emergency medical team left and I had him wait a while longer.   I had him call his mother to come and pick him up so he did not have to drive himself.  His mother arrived about 20 minutes later and I went over with her what had happened.  She took him home and I called to check on him after a few hours and he said he was doing fine.   He also stated while talking with him that he had never passed out when getting other vaccines or the flu shots previously.  He did state that he didn't like needles but was not afraid to get the vaccine.
his child had a PROQUAD vaccine on an unspecified date and has had "nothing but problems"; This spontaneous report was received from the patient's father, referring to a child patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications were not reported.  On an unspecified date, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (PROQUAD) administered as prophylaxis (dose, route of administration, vaccination scheme, frequency, anatomical injection site, lot number and expiration date were not reported). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (strength, dose, frequency, route of administration, indication, lot number and expiration date were not reported). The reporter stated that the patient had the vaccine and had had "nothing but problems" (ill-defined disorder).   The outcome of the event ill-defined disorder and the causal relationship between the aforementioned event with measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (PROQUAD) and sterile diluent (MERCK STERILE DILUENT) were not reported.
When COVID vaccine was received from state on 12/17/21 an incorrect Beyond Use Date was assigned to the vaccine by the receiving pharmacist.  The date assigned was 1/18/22 when it should have been 1/17/22.
The patient was administered Pfizer Biv 6 days before the vaccine was supposed to be administered
Information has been received from a nurse concerning a 15 year old female with anxiety who on 03-JAN-2008 was vaccinated intramuscularly with her third dose of GARDASIL (lot# not provided).  On 04-JAN-2008 the patient started experiencing morning sickness.  The patient's morning sickness persisted.  She sought unspecified medical attention.  The patient did not have any AE after the 1st or 2nd dose of GARDASIL.  Additional information has been requested.
Severe itching all over; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Jun-2021 and was forwarded to Moderna on 28-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Severe itching all over) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Severe itching all over). At the time of the report, PRURITUS (Severe itching all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Information has been received from a certified medical assistant concerning a patient with contraception who on 07-FEB-2007 was vaccinated with second dose of Gardasil (Lot#655503/0012U). Concomitant therapy included YASMIN, PAXIL and PROTONIX. On 07-FEB-2007, the patient experienced fainted (patient outcome not provided). Additional information has been requested. The same source also provided information regarding other patients' experiences (WAES#0703USA01200 and WAES#0703USA04319).
Hives; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives). The patient was treated with PREDNISONE for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
2/4/12 redness at site, swelling. 2/4/12 E.R. visit Rx Cephalexin Dx cellulitis. 2/5/12 E.R. visit 2 shots antibiotic & Rx another antibiotic. Dx - Cellulitis. Fu with PMD today 2/6 seems "a little better" & hydrocortisone cream for itchiness.
Breakthrough case admission after 2 vaccines Moderna 2/12/21 Lot# 015M20A;  MOderna 3/12/21 Lot# 030A21A
Site: Swelling at Injection Site-Medium, Systemic: Lymph Node Swelling-Medium
expired PENTACEL was administered to one of their patients in October with no reported adverse event; Initial information was received on 05-Dec-2022 regarding an unsolicited valid  non-serious case received from a healthcare professional.  This case involves a 18 months old female patient who was administered expired Diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [pentacel (VERO)] to one of their patients in october with no reported adverse event.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included: Hepatitis A vaccine (Hepatitis A) and Pneumococcal vaccine CONJ 13V (CRM197) (Prevnar 13) for prophylactic vaccination.  On 06-Oct-2022, the patient received expired Diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine at a dose of 0.5 ml (lot UJ57AA, expiration date: 11-Sep-2022) via intramuscular route in the right thigh for immunization to one of their patients in October with no reported adverse event (expired product administered) (unknown latency).    Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
During my annual physical exam (age 65) I received a PREVNAR 13 vaccine. On the following day and until now I have bad joint pain, stiffness and mild swelling of the joints which I never had prior to the injection. The worst symptoms are in my finger joints but also generalized. I also had a painful injection site which lasted only a few days.
Heavy, bright red bleeding at injection site over 15+ hours after the injection. Severe, sharp arm pain when the injection was administered. Bruising on right arm has been developing. Deep body aches and joint pain on legs, headache, fatigue.
Patient developed a fever of 105 degrees for 5 hours after receiving an influenza vaccine. The fever lasted about 7 hours, which the Mother treated with Tylenol.
Itching at site the day after immunization.  Warm red rash extending 5-7 cm around site 6 days after immunization.  No fever, chills, drainage.  Seen in office on day 7 and treated with cephalexin and xyzal due to possibility of cellulitis and itching/swelling.  Unclear if all local allergic reaction or secondary infection since rash didn't develop for 6 days, despite onset of itching within 24 hours.
Large bruise at injection site that formed a 3 inch by 3 inch red, hardened, raised welt just below it.  The welt appeared about a week and a half after the bruise. The day the welt appeared, fever, chills, and fatigue also presented. The welt is getting larger each day, and is more pronounced after showering.
Pt received first SHINGRIX dose on 4/27, felt a bit fatigued and had mild symptoms. Almost immediately, arm got swollen at site of injection. Area was painful, red, sore and looked like man's muscle. Patient went home, went straight to bed because was fatigued and a terrible headache started. It was a very odd headache. Usually headache, from one brow to the other but this headache was different. There was lot of pressure atop of head and daggers coming out from base of head. Headache lasted to Monday; did not take any meds. Also had upset stomach; threatening to throw up. That day patient could only tolerate water. Next day was able to tolerate some ginger ale and crackers. On the third day, had chicken soup and threw up. During the weekend, maybe had slight fever/felt hot. Also arm was hot to touch and hurt really bad. Rash was directly under the bandage. Patient did not go anywhere for 3 days since felt weak and dizzy. Slowly, patient finally started to feel better by Monday. The redness at site and heat continued. Had follow-up apt to surgeon to remove stich on 10/18. By then swelling was gone but mark at injection site was still thereit was brownish not red; it was still sore. Told pharmacy about symptoms and was told to report it. Patient slowly got back to activities. Today, has recovered completely.
A couple of months following dose 3 of Lymerix, the pt experienced unspecified symptoms. She subsequently diagnosed herself with traveling arthritis. The pt stated that her primary care physician has not diagnosed her with "traveling arthritis. As of 5/2/01, the outcome of the event was ongoing.
RASH, BRUISING ON CHEEKS AND CENTRAL UPPER LIP, PETECHIAE ON CHEST AND EXTREMITIES.
Fever of 102 degrees - achy muscles - chills, swelling and redness at site of the injection.
Acutely painful & swollen elbow after shoveling snow 2/2/21 that was drained 2/8/21 and labwork showed inflammatory process without infection.  Severe and debilitating widespread muscle cramps, mostly legs /hamstrings, low grade fever, extreme fatigue. Antibiotics started 2/8/21 while lab for Lyme pending.  Condition worsened until Lyme ruled out and prednisone started 2/16/21 providing some immediate relief.  Onset of systemic inflammatory process remains mystery.
This is a spontaneous report received from a contactable consumer or other non-HCP (the patient). A patient (no qualifiers provided) received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunization. Medical history and concomitant medications not reported. The patient experienced malaise (I am not really well; I am not well"), and fatigue ("wears me out too much trying to talk"), with outcome of unknown. Additional information: Patient was not really well. It wore them out too much trying to talk. Patient was not well and having trouble understanding. Reporter type could not be probed over the call hence captured as consumer or other non-healthcare professional by default. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information  expected.
Patient received Pentacel on 8/18/23. Vaccine had expired on 9/16/23. No adverse reaction occurred due to this.
The morning after I got the vaccine I noticed a rash all over my body in the form of bright red blotches from approximately 1" across. Several are angry looking. Generally not itchy. On legs, torso & arms. Approximately 2 dozen blotches. I am now on day 3 post inoculation and the blotches have not faded. No difficulty breathing.  Vaccine was administered by Pharmacist.
Information has been received from a registered nurse (R.N.) concerning a 10 year old male student with rhinitis allergic who on 16-APR-1999 and 03-JUN-2008 was vaccinated subcutaneously with first and second doses, respectively. of VARIVAX (Oka/Merck) (Lot # of second dose 659357/1567U).  Concomitant therapy included FLONASE, ALLEGRA and BENADRYL.  On 04-JUN-2008 the patient developed swelling and tenderness.  On 05-JUN-2008 the patient developed redness with swelling.  The area was outlined in pen.  On 06-JUN-2008 the patient's swelling and redness extended outside circled area.  The patient was treated with cephalexin, 250 mg/ 5 ml, 2 tsp every 12 hours for 10 days.  At the time of the report, the patient had not recovered from the events.  The reporter considered swelling, tenderness and redness to be important medical events.  This is one of several reports from the same source.  Additional information is not expected.